Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06686121 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Mobility After Revascularization in Peripheral Artery Disease

Study acronym: IMPACT PAD
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study sites: 7 to 8
    • Eligibility criteria expanded, about 31 words
    • Secondary endpoints: details revised at 5 of 6 entries
    • Collaborators: 7 to 8
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2025 to Aug 4, 2025
    • Site details revised at 7 of 7 sites
    v4
  3. Minor Study description expanded, about 3 wordsv3
  4. Notable Primary endpoints: 2 to 1v2 Show 4 more changesShow less
    • Study sites: 8 to 7
    • Eligibility criteria shortened, about 35 words
    • Secondary endpoints: 5 to 6
    • Collaborators expanded, about 22 words
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ischemia. However, supervised exercise is inaccessible or burdensome for most PAD patients. Investigators hypothesize that home-based exercise combined with lower extremity revascularization will significantly improve walking performance compared to revascularization alone in patients with PAD undergoing revascularization for disabling PAD. Investigators further hypothesize that inorganic nitrate, a major source of nitric oxide (NO) abundant in beetroot juice, will improve walking performance after lower extremity revascularization, compared to placebo. In preclinical models, NO inhibits inflammation, neointimal hyperplasia, thrombosis, and vascular smooth muscle cell migration at sites of revascularization. NO increases angiogenesis and perfusion, repairs skeletal muscle damaged by ischemia, and stimulates mitochondrial activity. In a randomized clinical trial with a 2 x 2 factorial design, the trial will test the following two primary hypotheses in 386 patients randomized within three months of a successful lower extremity revascularization for disabling PAD: First, that home-based exercise combined with lower extremity revascularization will improve six-minute walk distance more than revascularization alone at 6-month follow-up (Primary Aim #1). Second, that nitrate-rich beetroot juice combined with lower extremity revascularization will improve six-minute walk, compared to placebo combined with revascularization at 6-month follow-up (Primary Aim #2).
Trial Details
NCT Number NCT06686121
Lead Sponsor Northwestern University
Collaborators: Rancho Research Institute, Inc., University of Chicago, Wake Forest University, University of Pittsburgh Medical Center, Emory University, University of Arizona, Dartmouth-Hitchcock Medical Center, Henry Ford Health + Michigan State University Health Sciences
Conditions
(from sponsor)
Peripheral Artery Disease, Intermittent Claudication, Peripheral Vascular Disease, Mobility Limitation, Revascularization
Related terms Intermittent Claudication, Mobility Limitation, Peripheral Arterial Disease, Peripheral Vascular Diseases
Enrollment 386 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov